CIPLA (78)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces demat auction settlement for 98 scrips with failed delivery obligations across various securities. | |||||||||||||||
BSE announces demat auction settlement for 98 scrips with failed delivery obligations across various securities.
| |||||||||||||||
BSE demat auction settlement listing securities and quantities to be auctioned for settlement number 798 dated January 16, 2026. | |||||||||||||||
BSE demat auction settlement listing securities and quantities to be auctioned for settlement number 798 dated January 16, 2026.
| |||||||||||||||
BSE demat auction settlement listing scrips and quantities for settlement number 798 dated January 16, 2026. | |||||||||||||||
BSE demat auction settlement listing scrips and quantities for settlement number 798 dated January 16, 2026.
| |||||||||||||||
BSE announces the list of 139+ companies eligible for trading in Group A segment, representing high liquidity and quality securities … | |||||||||||||||
BSE announces the list of 139+ companies eligible for trading in Group A segment, representing high liquidity and quality securities including major blue-chip stocks across various sectors.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across … | |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across various sectors.
| |||||||||||||||
BSE has released the updated list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major … | |||||||||||||||
BSE has released the updated list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks like HDFC Bank, Infosys, Kotak Mahindra Bank, and JSW Steel.
| |||||||||||||||
BSE has updated the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment. | |||||||||||||||
BSE has updated the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment.
| |||||||||||||||
NSE announces listing of further equity shares for 18 companies including ICICI Bank, Cipla, Coforge, and others, primarily under ESOP … | |||||||||||||||
NSE announces listing of further equity shares for 18 companies including ICICI Bank, Cipla, Coforge, and others, primarily under ESOP schemes, effective December 24, 2025.
| |||||||||||||||